期刊文献+

DE4D基因多态性与急性缺血性卒中及阿司匹林抵抗的相关性 被引量:4

Correlation of DE4D Polymorphisms Associated with Acute Ischemic Stroke and Aspirin Resistance
原文传递
导出
摘要 本研究选取2015年1月至2016年1月来我院就诊的183例急性缺血性脑卒中患者(脑卒中组)与同期就诊非脑卒中患者183例(对照组),分别进行DE4D基因多态性检测。对比两组中的SNP83发现脑卒中组基因型CC与CT分别高达77.05%、20.77%,而且C等位基因为87.43,均明显高于对照组;对比SNP87发现,在各基因型与等位基因的比较中,脑卒中组与对照组无明显差异。脑卒中组,SNP83与SNP87的CT、CC、TT基因型占比在对阿司匹林敏感患者中与对阿司匹林抵抗的患者中无明显差异。DE4D基因SNP83与急性缺血性卒中有密切联系,其中C等位基因越高,发病风险越高,相对应SNP87则与该疾病发生相关性较小,这可为早期诊断及预防缺血性脑卒中提供强有力的理论依据。 Patients with acute ischemic stroke(stroke group) with the same period of non-treatment of stroke patients(control group) in our hospital were selected,183 respectively,to test the polymorphism of DE4D,from January 2015 to January 2016.We analyzed the SNP83 of DE4D in each group and found that the propotion of genotype CC and CT in stroke group were as high as 77.05%,20.77%,the C allele 87.43%,significantly higher than that of the control.However,the SNP83 and SNP87 of DE4D didn't show a significant difference.In the stroke group,the propotion of CT,CC,TT were of no difference between aspirin-sensitive patients and aspirin-resistant patients.SNP83 in DE4D gene was closely linked to acute ischemic stroke,where the C allele is the higher,the risk is the greater.However,SNP87 was of less correlation to the disease.The research may provide a strong theoretical basis for early diagnosis and prevention of ischemic stroke.
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2016年第6期1284-1287,共4页 Genomics and Applied Biology
关键词 DE4D 基因多态性 急性缺血性卒中 阿司匹林抵抗 DE4D Polymorphisms Acute ischemic stroke Aspirin resistance
  • 相关文献

参考文献11

二级参考文献94

  • 1徐淑兰,张颖冬,林兴建.磷酸二酯酶4D基因多态性与缺血性脑血管病的关系[J].临床神经病学杂志,2008,21(4):249-252. 被引量:12
  • 2李才明,张成,张鸿炼,冯慧宇,苏全喜,卢锡林.磷酸二酯酶4D基因与缺血性脑卒中的遗传易患性研究[J].中华神经科杂志,2006,39(3):180-183. 被引量:15
  • 3Pulcinelli FM, Biasucci LM, Riondino S, et al. COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment[J]. Eur Heart J, 2009, 30(10).. 1279-1286.
  • 4Watala C, Colanskij C, Waczulikova L, et al. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study[J], Blood Coagul Fibrinolysis, 2006, 17(2): 113-124.
  • 5Zczeklik A, Musia J, Undas A, et al. Aspirin resistance[J]. J Yhromb Haemost, 2005, 3(8): 1655-1662.
  • 6Horiuchi H. Recent advance in antiplatelet therapy: the meehanisms evidence and approach to the problems[J]. Ann Med, 2006, 38(3): 162-172.
  • 7Krasopoulos G, Brister S J, Beattie WS, et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis[J]. BMJ, 2008, 336(7637): 195-198.
  • 8Lancaster GI, Srinivasan J, Jain H, et al. Aspirin resistance: an update[J]. Curt Atheroscler Rep, 2009,11 (2): 105-110.
  • 9Cambria-Kiely JA, Gandhi PJ. Possible mechanisms ofaspirin resistance[J]. J Thromb Thrombol, 2002, 13(1): 49-56.
  • 10Zimmermann N, Weber AA, Hoglfeld T. Aspirin "Resistance" [J]. Herz, 2008, 33(4): 270-278.

共引文献39

同被引文献53

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部